Abstract
Health research using electronic health records (EHR) has gained popularity, but misclassification of EHR-derived disease status and lack of representativeness of the study sample can result in substantial bias in effect estimates and can impact power and type I error. In this paper, we develop new strategies for handling disease status misclassification and selection bias in EHR-based association studies. We first focus on each type of bias separately. For misclassification, we propose three novel likelihood-based bias correction strategies. A distinguishing feature of the EHR setting is that misclassification may be related to patient-specific factors, and the proposed methods leverage data in the EHR to estimate misclassification rates without gold standard labels. For addressing selection bias, we describe how calibration and inverse probability weighting methods from the survey sampling literature can be extended and applied to the EHR setting.
Addressing misclassification and selection biases simultaneously is a more challenging problem than dealing with each on its own, and we propose several new strategies to address this situation. For all methods proposed, we derive valid standard errors and provide software for implementation. We provide a new suite of statistical estimation and inference strategies for addressing misclassification and selection bias simultaneously that is tailored to problems arising in EHR data analysis. We apply these methods to data from The Michigan Genomics Initiative (MGI), a longitudinal EHR-linked biorepository.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was supported by The University of Michigan Comprehensive Cancer Center core grant supplement 5P30-CA-046592, NSF DMS award 1712933 and The University of Michigan precision health award U067541.
Author Declarations
All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.
Yes
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
MGI data are available after IRB approval to select researchers.